Ozuriftamab (CAS: 2460399-44-2)
Ozuriftamab is a human IgG1κ monoclonal antibody targeting ROR2, a protein involved in cancer progression.
Key Features:
- Target: Binds specifically to ROR2, expressed in various cancers.
- Action: Can be used to create antibody-drug conjugates (ADCs) that deliver cytotoxic agents directly to ROR2-expressing tumor cells.
- Therapeutic Use: Investigated for treating cancers like head and neck squamous cell carcinoma (HNSCC).
Applications:
- Cancer Research: Develops ADCs for ROR2-expressing tumors, improving treatment precision and reducing side effects.
- Therapeutic Development: Used to create ADCs that target ROR2-positive cancers with cytotoxic drugs.
Handling and Storage:
- Storage: Keep at -20°C, shielded from light.
- Precautions: Use personal protective equipment and ensure proper ventilation during handling.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
